Bryn Mawr Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $283K | Hold |
|
|||||
|
2025
Q2 | $274K | Sell |
|
|||||
|
2025
Q1 | $273K | Buy |
|
|||||
|
2024
Q4 | $334K | Hold |
|
|||||
|
2024
Q3 | $356K | Hold |
|
|||||
|
2024
Q2 | $374K | Hold |
|
|||||
|
2024
Q1 | $490K | Hold |
|
|||||
|
2023
Q4 | $428K | Hold |
|
|||||
|
2023
Q3 | $355K | Sell |
|
|||||
|
2023
Q2 | $394K | Hold |
|
|||||
|
2023
Q1 | $379K | Hold |
|
|||||
|
2022
Q4 | $409K | Sell |
|
|||||
|
2022
Q3 | $373K | Buy |
|
|||||
|
2022
Q2 | $401K | Buy |
|
|||||
|
2022
Q1 | $514K | Hold |
|
|||||
|
2021
Q4 | $682K | Hold |
|
|||||
|
2021
Q3 | $747K | Hold |
|
|||||
|
2021
Q2 | $669K | Hold |
|
|||||
|
2021
Q1 | $524K | Hold |
|
|||||
|
2020
Q4 | $452K | Hold |
|
|||||
|
2020
Q3 | $410K | Hold |
|
|||||
|
2020
Q2 | $315K | Hold |
|
|||||
|
2020
Q1 | $228K | Hold |
|
|||||
|
2019
Q4 | $276K | Hold |
|
|||||
|
2019
Q3 | $239K | Hold |
|
|||||
|
2019
Q2 | $257K | Hold |
|
|||||
|
2019
Q1 | $263K | Hold |
|
|||||
|
2018
Q4 | $205K | Hold |
|
|||||
|
2018
Q3 | $243K | Hold |
|
|||||
|
2018
Q2 | $203K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $205K | Buy |
|